Further validation showed that the expression of SEC14L2 and SLC6A in 371 liver cancers was lower than that in 50 paracancer samples; 50 samples were paired to explain the expression of the genes in cancer and paracancer tissues (Figures 8C and 8D). This evidence concerns the gene SEC14L2 and cancer.